Mutated forms of the protein p21c-ras are associated with the development of a substantial proportion of tumors. However, a second mutation that changes the Cys residue in the Cterminal Cys-X-X-Y sequence of p21c-ras to some other residue inhibits its cancer-causing potential. What does this suggest about the molecular process leading to tumor formation?